Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
01/2008
01/24/2008CA2657936A1 Antiviral protease inhibitors
01/24/2008CA2657850A1 Novel pyridazine derivatives
01/23/2008EP1880720A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
01/23/2008CN101111479A Pyridones used as inhibitors of kinases
01/22/2008US7321046 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
01/22/2008CA2214321C Novel taxoids, preparation thereof and pharmaceutical compositions containing same
01/17/2008WO2008006560A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
01/17/2008WO2008006372A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline
01/17/2008WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
01/17/2008CA2657062A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
01/16/2008EP1878726A1 Substituted sulphoximines as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same and uses of the same
01/16/2008EP1877376A1 Novel compounds for treating inflammatory diseases
01/16/2008CN101104616A Dehydrosilibinin diester derivatives, preparation method and use thereof
01/16/2008CN100361990C Second order non-linear optical chromophore containing indolyl radical and its prepn and application
01/15/2008US7318966 Luminescent element material and luminescent element comprising the same
01/10/2008WO2008006113A2 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis
01/10/2008WO2008006040A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/10/2008WO2008006032A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/10/2008WO2007136572A3 Antidiabetic bicyclic compounds
01/10/2008WO2007131764A3 New heterocyclic compounds for the inhibition of integrins and use thereof
01/10/2008WO2007127309A3 Processes for the synthesis of 3-isobutylglutaric acid
01/10/2008WO2007062158A3 Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof
01/10/2008CA2657103A1 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis
01/10/2008CA2656622A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/10/2008CA2656618A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/09/2008EP1874760A1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer
01/08/2008US7317114 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities
01/08/2008US7317113 Treatment of 7-Boc-13-keto-baccatin III to give 7-Boc-13-keto-14-hydroxy-baccatin III, carbonation of the 1 and 14 hydroxyls to give 14 beta -hydroxy-7-Boc-keto-baccatin III-1,14-carbonate, and reduction of the ketone at the 13-position and cleavage of the protective group
01/08/2008CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
01/03/2008WO2008000645A1 Tetrazole-substituted arylamides
01/03/2008WO2008000407A1 Inhibitors of cxcr2
01/03/2008CA2654915A1 Tetrazole-substituted arylamides
01/02/2008EP1871755A1 Dihydrobenzofuran derivatives and uses thereof
01/02/2008EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
01/02/2008EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
01/02/2008CN100358901C Cross-linked glycopeptide-cephalosporin antibiotics
01/02/2008CN100358891C Pyranones useful as ATM inhibitors
01/01/2008US7314938 Immune and/or inflammatory disorders; autoimmune disorders; disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1); antagonize CD11/CD18 receptors associated with leukocytes.
01/01/2008US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders
12/2007
12/27/2007WO2007149448A2 Pyrazinones as cellular proliferation inhibitors
12/27/2007WO2007149033A1 Substituted isoindoles as bace inhibitors and their use
12/27/2007WO2007148412A1 Novel fki-3389 substance and method for producing the same
12/27/2007WO2007147770A2 Substituted phenyl methanone derivatives
12/27/2007WO2007094922A3 Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents
12/27/2007CA2656625A1 Substituted isoindoles as bace inhibitors and their use
12/27/2007CA2653355A1 Substituted phenyl methanone derivatives
12/27/2007CA2652859A1 Pyrazinones as cellular proliferation inhibitors
12/26/2007EP1869040A1 Dna-pk inhibitors
12/26/2007EP1869021A1 Dna-pk inhibitors
12/26/2007EP1869013A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
12/26/2007EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives
12/26/2007CN101094851A Novel compound having lipase inhibitory activity
12/26/2007CN100357280C Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient
12/25/2007US7312230 Carboxylic acid derivatives as IP antagonists
12/25/2007US7312048 Recombinant production of novel polyketides
12/21/2007WO2007093529A3 Heteroaroyl-substituted alanines
12/21/2007CA2654927A1 Substituted phenyl acetic acids as dp-2 antagonists
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/19/2007EP1546152B1 Epothilone derivatives
12/19/2007EP1165068B1 C10 heterosubstituted acetate taxanes as antitumor agents
12/19/2007CN101090898A 5-HT7 receptor antagonists
12/19/2007CN100355766C Method for preparing and purifying uperarin through membrane technology
12/19/2007CN100355738C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
12/18/2007CA2217074C Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis
12/13/2007WO2007109654A3 Docetaxel polymorphs and processes
12/13/2007DE102004040014B4 Aureonitrile, Verfahren zu ihrer Herstellung und ihre Verwendung Aureonitrile, processes for their preparation and their use
12/12/2007EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
12/12/2007CN101085760A Ligustrazine stilbenoids derivatives, preparation method thereof, medicament composition and use
12/11/2007US7307128 A curable compound, or adduct, or epoxy resins of anthrahydroquinone and epichlorohydrin; phenolic resin as curing agents; cured product is used for semiconductor encapsulation; solid, low melt viscosity, flame retardance, halogen-free; mechanical strength, heat resistance, moisture resistance
12/11/2007US7307100 2-Benzoylchromone derivatives
12/06/2007WO2007139496A1 Quinoline derivatives acting as tyrosine kinase inhibitors
12/06/2007US20070281946 Tri(cyclo) substituted amide compounds
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007CN101081848A Novel polyenes and preparation method and usage thereof
12/05/2007CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
12/05/2007CN100352810C Fumagillol derivatives and processes for preparing the same
12/05/2007CN100352807C Chemical compounds
12/04/2007US7304120 Preparing a curable compound, or adduct, or epoxy resins of anthrahydroquinone and epichlorohydrin; cured product is used for semiconductor encapsulation; solid, low melt viscosity, flame retardance, halogen-free; mechanical strength, heat and moisture resistance
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007CA2418125C Beta-lactams useful in the preparation of substituted isoserine esters
11/2007
11/29/2007WO2007136574A2 Medical devices having polymeric regions based on vinyl ether block copolymers
11/29/2007WO2007136572A2 Antidiabetic bicyclic compounds
11/29/2007WO2007135954A1 2-oxetanone derivative and process for production thereof
11/29/2007WO2007135565A2 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
11/29/2007WO2007135417A1 Benzotriazepinone derivatives
11/29/2007WO2007110705A3 Macrolide as inhibitors of mhc class ii
11/29/2007WO2007107385A3 Soluble adenylate cyclase inhibitors
11/29/2007US20070276005 Tri-substitued 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6 disubstituted pyran derivatives
11/29/2007CA2651153A1 Antidiabetic bicyclic compounds
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/28/2007EP1860104A1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
11/28/2007EP1534674A4 Cytotoxic agents containing novel potent taxanes and their therapeutic use
11/28/2007CN101080396A Quinoxalines as B Raf inhibitors
11/28/2007CN101077852A Preparation for chemical component of Shenmai injection and application of the same in curing cardio-cerebrovascular disease
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007CA2199624C Polymerizable aromatic carboxylic acids and carboxyanhydrides with cyclic carbonate groups, as well as preparations containing these compounds
11/22/2007WO2007132496A1 Dioxaspiroketal derivatives, process for their preparation and uses thereof
11/22/2007WO2007131764A2 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007WO2007131446A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
11/22/2007US20070270485 Byrostatin analogues, synthetic methods and uses
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 120